MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Experimental biology and medicine

• Publication date

  2013-08-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1535370213497321PMID 23925649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs as Oncogenes and Tumor Suppressors

  2013cited by this paper
• Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance.

  2012cited by this paper
• Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer

  2012influential reference
• Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells

  2012influential reference
• MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.

  2012influential reference
• Hepatocellular carcinoma

  2012cited by this paper
• Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics

  2012cited by this paper
• miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

  2011cited by this paper
• Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

  2011cited by this paper
• MicroRNA-301 mediates proliferation and invasion in human breast cancer.

  2011cited by this paper
• MicroRNA‐125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B 2

  2010cited by this paper
• Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics

  2010cited by this paper
• MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

  2010cited by this paper
• Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma

  2009cited by this paper
• MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.

  2008influential reference
• Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas.

  2007cited by this paper
• An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.

  2006cited by this paper
• The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research

  2006cited by this paper
• MicroRNAs as oncogenes and tumor suppressors.

  2005cited by this paper
• A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

  2005cited by this paper
• P‐glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell‐lines

  2005cited by this paper
• A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

  2005cited by this paper
• Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• The role of ABC transporters in clinical practice.

  2003cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper

• MiRNAs: main players of cancer drug resistance target ABC transporters

  2025cites this paper
• Insights into the genetic and epigenetic mechanisms governing X-chromosome-linked-miRNAs expression in cancer; a step-toward ncRNA precision.

  2024cites this paper
• MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters

  2024cites this paper
• MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma

  2024cites this paper
• MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities

  2024cites this paper
• Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

  2024cites this paper
• Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells

  2024cites this paper
• Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate

  2024cites this paper
• The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance

  2024cites this paper
• Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp

  2023cites this paper
• Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming.

  2023cites this paper
• Engineered Biosensors for Diagnosing Multidrug Resistance in Microbial and Malignant Cells

  2023cites this paper
• Ultrasound-mediated immune regulation in tumor immunotherapy

  2022cites this paper
• Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients

  2022cites this paper
• The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis.

  2022cites this paper
• Polysaccharides Produced by the Mushroom Trametes robiniophila Murr Boosts the Sensitivity of Hepatoma Cells to Oxaliplatin via the miR-224-5p/ABCB1/P-gp Axis

  2022cites this paper
• Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium

  2022cites this paper
• MicroRNA as a Potential Therapeutic Molecule in Cancer

  2022cites this paper
• The Roles of microRNAs in Cancer Multidrug Resistance

  2022cites this paper
• Regulation of MRP4 Expression by circHIPK3 via Sponging miR-124-3p/miR-4524-5p in Hepatocellular Carcinoma

  2021cites this paper
• Flavonoid display ability to target microRNAs in cancer pathogenesis.

  2021cites this paper
• miR-381 Reverses Multidrug Resistance by Negative Regulation of the CTNNB1/ABCB1 Pathway in HepG2/Dox Cells, and the Diagnostic and Prognostic Values of CTNNB1/ABCB1 Are Identified in Patients with LIHC

  2021cites this paper
• The role of non-coding RNAs in chemotherapy for gastrointestinal cancers

  2021cites this paper
• A Literature Curated Profile of miRNA IN Modulating Multi-Drug Resistance for Cancer Therapy

  2021cites this paper
• Regulation of drug transporters by microRNA and implications in disease treatment

  2021cites this paper
• Dysregulation of Non-coding RNAs mediates Cisplatin Resistance in Hepatocellular Carcinoma and therapeutic strategies.

  2021cites this paper
• Regulation of drug transporters by microRNA and implications in disease treatment

  2021cites this paper
• miRNA-223-3p modulates ibrutinib resistance through regulating CHUK/NF-κB signaling pathway in mantle cell lymphoma.

  2021cites this paper
• Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma

  2021cites this paper
• Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.

  2021cites this paper
• MicroRNA Therapeutics in Cancer: Current Advances and Challenges

  2021cites this paper
• The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response

  2021cites this paper
• MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer

  2020cites this paper
• Implications of genome plasticity for drug development

  2020cites this paper
• MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma

  2020cites this paper
• microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance

  2020cites this paper
• ABC Efflux Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug Resistance

  2020cites this paper
• miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells

  2019cites this paper
• ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma.

  2019cites this paper
• ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells.

  2019cites this paper
• CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer

  2019cites this paper
• The role and mechanisms of action of microRNAs in cancer drug resistance

  2019cites this paper
• Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review

  2019cites this paper
• Study of serum microRNA19a and microRNA223 as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma

  2019cites this paper
• MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma

  2019cites this paper
• ABCB1 protects bat cells from DNA damage induced by genotoxic compounds

  2019cites this paper
• SIRT1 in the Development and Treatment of Hepatocellular Carcinoma

  2019cites this paper
• The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma

  2019cites this paper
• Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease

  2019cites this paper
• The role of microRNA in the resistance to treatment of hepatocellular carcinoma.

  2019cites this paper
• MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies

  2019cites this paper
• MicroRNA‐mediated suppression of P‐glycoprotein by quantum dots in lung cancer cells

  2019cites this paper
• From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs

  2019cites this paper
• Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines.

  2018cites this paper
• The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma

  2018cites this paper
• Serum mir-30e and mir-223 as novel noninvasive biomarkers for hepatocellular carcinoma

  2018cites this paper
• The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo

  2018cites this paper
• Significance of A‐to‐I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics

  2018cites this paper
• How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?

  2018cites this paper
• The Significance of Regulatory MicroRNAs: Their Roles in Toxicodynamics of Mycotoxins and in the Protection Offered by Dietary Therapeutics Against Mycotoxin-Induced Toxicity.

  2018cites this paper
• Role of miR-223 in the pathophysiology of liver diseases

  2018cites this paper
• Autophagy activation contributes to glutathione transferase Mu 1-mediated chemoresistance in hepatocellular carcinoma

  2018cites this paper
• Non-coding RNA in drug resistance of hepatocellular carcinoma

  2018cites this paper
• Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors

  2018cites this paper
• Potential role of microRNA-223-3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics

  2017cites this paper
• Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway

  2017cites this paper
• Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.

  2017cites this paper
• A proteomics-based investigation on the anticancer activity of alisertib, an Aurora kinase A inhibitor, in hepatocellular carcinoma Hep3B cells.

  2017cites this paper
• Integrated analysis of miRNA expression in response to Salmonella Typhimurium infection in pigs

  2017cites this paper
• MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells

  2017cites this paper
• The role of miRNA-223 in cancer: Function, diagnosis and therapy.

  2017cites this paper
• Epigenetic regulation of drug transporter expression in human tissues

  2017cites this paper
• MicroRNAs in hepatocellular carcinoma – therapeutics and beyond: A systematic review

  2017cites this paper
• Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase

  2017cites this paper
• The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma.

  2017cites this paper
• Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance.

  2016cites this paper
• MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy

  2016cites this paper
• MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression

  2016cites this paper
• Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.

  2016cites this paper
• miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway

  2016cites this paper
• Regulation of multidrug resistance by microRNAs in anti-cancer therapy

  2016cites this paper
• MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.

  2016cites this paper
• HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma.

  2016cites this paper
• ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview

  2016cites this paper
• MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells

  2016cites this paper
• Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine

  2016cites this paper
• Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes

  2016cites this paper
• miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1

  2016cites this paper
• Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer.

  2016cites this paper
• MicroRNAs as key mediators of hepatic detoxification.

  2016cites this paper
• Mechanisms of doxorubicin resistance in hepatocellular carcinoma.

  2016cites this paper
• Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review

  2016cites this paper
• MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas

  2015cites this paper
• miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2

  2015cites this paper
• epatomiRNoma : The proposal of a new network of targets for iagnosis , prognosis and therapy in hepatocellular carcinoma

  2015cites this paper
• Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers.

  2015cites this paper
• Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

  2015cites this paper
• Upregulation of UGT 2 B 4 Expression by 3 9-Phosphoadenosine-5 9-Phosphosulfate Synthase Knockdown : Implications for Coordinated Control of Bile Acid Conjugation s

  2015cites this paper
• Regulation of Multidrug Resistance Proteins by Genistein in a Hepatocarcinoma Cell Line: Impact on Sorafenib Cytotoxicity

  2015influential citation
• Effect of microRNA-21 on multidrug resistance reversal in A549/DDP human lung cancer cells.

  2015cites this paper